Asparaginase Erwinia chrysanthemi and Mogamulizumab-kpkc
Determining the interaction of Asparaginase Erwinia chrysanthemi and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: asparaginase erwinia chrysanthemi
Brand name: Erwinaze
Synonyms: Asparaginase (Erwinia)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Asparaginase Erwinia chrysanthemi-Mogamulizumab-kpkc Intravenous
- Asparaginase Erwinia chrysanthemi-Molindone
- Asparaginase Erwinia chrysanthemi-Mometasone (Oral Inhalation)
- Asparaginase Erwinia chrysanthemi-Mometasone and Formoterol
- Asparaginase Erwinia chrysanthemi-Mometasone and formoterol Inhalation
- Asparaginase Erwinia chrysanthemi-Mometasone Cream
- Mogamulizumab-kpkc-Asparaginase erwinia chrysanthemi Intramuscular
- Mogamulizumab-kpkc-Asparlas
- Mogamulizumab-kpkc-Aspercreme Lidocaine
- Mogamulizumab-kpkc-Aspergum
- Mogamulizumab-kpkc-Aspir 81
- Mogamulizumab-kpkc-Aspir-Low